TRACON Pharmaceuticals, Inc. TCON
0.03 0.00 (+0.00%)
At closeJul 16, 2025, 4:00 PM EDT
0.0322 Day range 0.04
0.60 52-week range 14.75
- YTD
- 0.00%
- 1 year
- -94.82%
TCON revenue history
Revenue is income from the company’s ordinary business activities.
12,045,000 USD
FY 2023 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | 12,045,000 | 12,045,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | -346,000 | -100.00% |
| FY 2021 | 2021-12-31 | 346,000 | 346,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | -3,000,000 | -100.00% |
| FY 2018 | 2018-12-31 | 3,000,000 | -5,755,000 | -65.73% |
| FY 2017 | 2017-12-31 | 8,755,000 | 5,306,000 | 153.84% |
| FY 2016 | 2016-12-31 | 3,449,000 | -4,455,000 | -56.36% |
| FY 2015 | 2015-12-31 | 7,904,000 | 4,306,000 | 119.68% |
| FY 2014 | 2014-12-31 | 3,598,000 | 3,598,000 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:22.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.